文献速递呼吸危重症与机械通气呼吸道感染

免疫功能受损ARDS患者的呼吸力学与结局:EFRAIM研究二次分析

Respiratory Mechanics and Outcomes in Immunocompromised Patients With ARDS: A Secondary Analysis of the EFRAIM Study.
PubMed 文献 · Chest · 2020-06-20

本研究为EFRAIM数据的预设二次分析,纳入494例符合柏林定义的免疫功能受损ARDS患者,评估呼吸力学指标与医院死亡率的关系。医院死亡率为56.3%,调整后病因未明、需血管升压药和肾脏替代治疗与死亡独立相关;将驱动压、平台压或顺应性分别加入模型后均与死亡显著相关。

要点

  • 免疫功能受损ARDS患者医院死亡率高(56.3%)。
  • 驱动压、平台压升高和顺应性降低与死亡风险增加相关。
  • 病因未明、需血管升压药或肾脏替代治疗独立预测死亡。

核心结论

  • 在免疫功能受损ARDS患者中,呼吸力学指标可提供额外的预后信息。

研究设计与样本

  • EFRAIM数据的预设二次分析,1611例中789例符合柏林ARDS标准,494例有呼吸力学数据。

主要发现

  • 医院死亡率为56.3%。
  • 调整后,病因未明(OR 1.66;95%CI 1.01-2.72)、需血管升压药(OR 1.91;95%CI 1.27-2.88)和肾脏替代治疗(OR 2.02;95%CI 1.37-2.97)与医院死亡独立相关。
  • 柏林定义ARDS严重度、入院时中性粒细胞减少及基础疾病类型与死亡率无显著关联。
  • 将驱动压(OR 1.08;95%CI 1.05-1.12)、平台压(OR 1.07;95%CI 1.04-1.11)或顺应性(OR 0.97;95%CI 0.95-0.98)分别加入最终模型后均与死亡率显著相关。
  • 潮气量与死亡率无关。

临床怎么用

  • 对免疫功能受损ARDS患者,可关注驱动压、平台压和顺应性以辅助预后评估。

局限性

  • 本研究为二次分析,仅494例患者有呼吸力学数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In view of the high mortality rate of immunocompromised patients with ARDS, it is important to identify targets for improvement. RESEARCH QUESTION: This study investigated factors associated with mortality in this specific ARDS population, including factors related to respiratory mechanics (plateau pressure [Pplat,rs], compliance [Crs], and driving pressure [ΔPrs]). STUDY DESIGN AND METHODS: This study consisted of a predefined secondary analysis of the EFRAIM data. Overall, 789 of 1,611 patients met the Berlin criteria for ARDS, and Pplat,rs, ΔPrs, and Crs were available for 494 patients. A hierarchical model was used to assess factors at ARDS onset independently associated with hospital mortality. RESULTS: Hospital mortality was 56.3%. After adjustment, variables independently associated with hospital mortality included ARDS of undetermined etiology (OR, 1.66; 95% CI, 1.01-2.72), need for vasopressors (OR, 1.91; 95% CI, 1.27-2.88), and need for renal replacement therapy (OR, 2.02; 95% CI, 1.37-2.97). ARDS severity according to the Berlin definition, neutropenia on admission, and the type of underlying disease were not significantly associated with mortality. Before adjustment, higher Pplat,rs, higher ΔPrs, and lower Crs were associated with higher mortality. Addition of each of these individual variables to the final hierarchical model revealed a significant association with mortality: ΔPrs (OR, 1.08; 95% CI, 1.05-1.12), Pplat,rs (OR, 1.07; 95% CI, 1.04-1.11), and Crs (OR, 0.97; 95% CI, 0.95-0.98). Tidal volume was not associated with mortality. INTERPRETATION: In immunocompromised patients with ARDS, respiratory mechanics provide additional prognostic information to predictors of hospital mortality. Studies designed to define lung-protective ventilation guided by these physiological variables may be warranted in this specific population.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Demoule A, Antonelli M, Schellongowski P, et al. Respiratory Mechanics and Outcomes in Immunocompromised Patients With ARDS: A Secondary Analysis of the EFRAIM Study. Chest. 2020. PMID: 32569634. doi:10.1016/j.chest.2020.05.602

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。